Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Divalproex Sodium Versus Olanzapine in the Treatment of Acute Mania in Bipolar Disorder: Health-Related Quality of Life and Medical Cost Outcomes PDF $40.00
$40.00
× Placeholder Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF $40.00
$40.00
× Placeholder Long-Term Safety and Efficacy of Ziprasidone in Subpopulations of Patients With Bipolar Mania PDF $40.00
$40.00
× Placeholder An 8-Week Open-Label Trial of a 6-Day Course of Mifepristone for the Treatment of Psychotic Depression PDF $40.00
$40.00
× Placeholder Long-Term Trajectories of Posttraumatic Stress Disorder in Veterans: The Role of Social Resources PDF $40.00
$40.00
× Placeholder Response to Antidepressant Medications in Late-Life Depression Across the Spectrum of Cognitive Functioning PDF $40.00
$40.00
× Placeholder Suicide Risk Assessment Received Prior to Suicide Death by Veterans Health Administration Patients With a History of Depression PDF $40.00
$40.00
× Placeholder COVID-19 and Physician Assistant Education: Big Changes in the Classroom, Bigger Changes in the Clinic PDF $40.00
$40.00
× Placeholder Switching Versus Augmentation: A Prospective, Naturalistic Comparison in Depressed, Treatment-Resistant Patients PDF $40.00
$40.00
× Placeholder Smoking as a Risk Factor for Mental Health Disturbances After a Disaster: A Prospective Comparative Study PDF $40.00
$40.00
× Placeholder Primary Care-Mental Health Integration Programs in the Veterans Affairs Health System Serve a Different Patient Population Than Specialty Mental Health Clinics PDF $40.00
$40.00
× Placeholder Triple-Bead Mixed Amphetamine Salts (SPD465), a Novel, Enhanced Extended-Release Amphetamine Formulation for the Treatment of Adults With ADHD: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study PDF $40.00
$40.00
× Placeholder Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar I Disorder: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial PDF $40.00
$40.00
× Placeholder Caffeine-Induced Psychosis in a Bodybuilder With Chronic Testosterone and Amphetamine/Dextroamphetamine Misuse PDF $40.00
$40.00
× Placeholder A Preliminary Open-Label Study of Zonisamide Treatment for Bipolar Depression in 10 Patients PDF $40.00
$40.00
× Placeholder Defining Response in Clinical Trials for Obsessive-Compulsive Disorder: A Signal Detection Analysis of the Yale-Brown Obsessive Compulsive Scale PDF $40.00
$40.00
× Placeholder Predictors of Long-Term and High-Dose Use of Zolpidem in Veterans PDF $40.00
$40.00
× Placeholder Complementary and Alternative Treatments for Late-Life Depression, Anxiety, and Sleep Disturbance: A Review of Randomized Controlled Trials PDF $40.00
$40.00
× Placeholder Neurocognitive Impairment and Psychosis in Bipolar I Disorder During Early Remission From an Acute Episode of Mood Disturbance PDF $40.00
$40.00
× Placeholder Sensitivity and Specificity of the Mood Disorder Questionnaire as a Screening Tool for Bipolar Disorder During Pregnancy and the Postpartum Period PDF $40.00
$40.00
× Placeholder Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications PDF $40.00
$40.00
× Placeholder Past Anabolic-Androgenic Steroid Use Among Men Admitted for Substance Abuse Treatment: An Underrecognized Problem? PDF $40.00
$40.00
× Placeholder Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting: A Review of Medication Profiles in 435 Canadian Outpatients PDF $40.00
$40.00
× Placeholder Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study PDF $40.00
$40.00
× Placeholder A 10-Month, Open-Label Evaluation of Desvenlafaxine in Outpatients With Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Unremitting Nausea Due to Lurasidone After Semaglutide Initiation PDF $40.00
$40.00
× Placeholder Problematic Video Game Use Scale: Initial Psychometric Properties With Psychiatrically Hospitalized Adolescents PDF $40.00
$40.00
× Placeholder A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness PDF $40.00
$40.00
× Placeholder Risperidone-Induced Tardive Dyskinesia in an Autistic Child PDF $40.00
$40.00
× Placeholder Poor Long-Term Prognosis in Mixed Bipolar Patients: 10-Year Outcomes in the Vitoria Prospective Naturalistic Study in Spain PDF $40.00
$40.00
× Placeholder Antidepressant-Induced Sexual Dysfunction During Treatment With Moclobemide, Paroxetine, Sertraline, and Venlafaxine PDF $40.00
$40.00
× Placeholder Effects of Levetiracetam on Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled Study PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $1,280.00
Total $1,280.00